Research progress of ferroptosis regulating lipid peroxidation and metabolism in occurrence and development of primary liver cancer

被引:1
作者
Shu, Yu-Jie [1 ]
Lao, Bo [1 ]
Qiu, Ying-Yang [2 ]
机构
[1] Yinzhou Dist Second Hosp, Dept Gastroenterol, 1 Qianhe Rd, Ningbo 315199, Zhejiang, Peoples R China
[2] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 119077, Singapore
关键词
Ferroptosis; Lipid peroxidation; Primary liver cancer; Lipid metabolism; Review; SORAFENIB-INDUCED FERROPTOSIS; HEPATOCELLULAR-CARCINOMA; EMERGING ROLE; PATHWAY; AUTOPHAGY; SLC7A11; MECHANISM; PROTECTS; THERAPY; CELLS;
D O I
10.4251/wjgo.v16.i6.2335
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
As a highly aggressive tumor, the pathophysiological mechanism of primary liver cancer has attracted much attention. In recent years, factors such as ferroptosis regulation, lipid peroxidation and metabolic abnormalities have emerged in the study of liver cancer, providing a new perspective for understanding the development of liver cancer. Ferroptosis regulation, lipid peroxidation and metabolic abnormalities play important roles in the occurrence and development of liver cancer. The regulation of ferroptosis is involved in apoptosis and necrosis, affecting cell survival and death. Lipid peroxidation promotes oxidative damage and promotes the invasion of liver cancer cells. Metabolic abnormalities, especially the disorders of glucose and lipid metabolism, directly affect the proliferation and growth of liver cancer cells. Studies of ferroptosis regulation and lipid peroxidation may help to discover new therapeutic targets and improve therapeutic outcomes. The understanding of metabolic abnormalities can provide new ideas for the prevention of liver cancer, and reduce the risk of disease by adjusting the metabolic process. This review focuses on the key roles of ferroptosis regulation, lipid peroxidation and metabolic abnormalities in this process.
引用
收藏
页码:2335 / 2349
页数:16
相关论文
共 110 条
  • [1] Alannan M., 2022, Cells, V12
  • [2] The mechanism and progress of ferroptosis in pancreatic cancer
    Bao, Zhi-Hang
    Hou, Xiang-Bin
    Li, Hao-Ling
    Mao, Yi-Feng
    Wang, Wen-Rui
    [J]. ACTA HISTOCHEMICA, 2022, 124 (06)
  • [3] Ferroptosis in Hepatocellular Carcinoma: Mechanisms, Drug Targets and Approaches to Clinical Translation
    Bekric, Dino
    Ocker, Matthias
    Mayr, Christian
    Stintzing, Sebastian
    Ritter, Markus
    Kiesslich, Tobias
    Neureiter, Daniel
    [J]. CANCERS, 2022, 14 (07)
  • [4] Macropinocytosis is an alternative pathway of cysteine acquisition and mitigates sorafenib-induced ferroptosis in hepatocellular carcinoma
    Byun, Jun-Kyu
    Lee, Seunghyeong
    Kang, Gil Won
    Lee, Yu Rim
    Park, Soo Young
    Song, Im-Sook
    Yun, Jae Won
    Lee, Jaebon
    Choi, Yeon-Kyung
    Park, Keun-Gyu
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2022, 41 (01)
  • [5] Astaxanthin Activated the Nrf2/HO-1 Pathway to Enhance Autophagy and Inhibit Ferroptosis, Ameliorating Acetaminophen-Induced Liver Injury
    Cai, Xiaopeng
    Hua, Shiyuan
    Deng, Jingwen
    Du, Zhen
    Zhang, Dongxiao
    Liu, Zhenfeng
    Khan, Nazif Ullah
    Zhou, Min
    Chen, Zhi
    [J]. ACS APPLIED MATERIALS & INTERFACES, 2022, 14 (38) : 42887 - 42903
  • [6] The Emerging Role of Ferroptosis in Liver Cancers
    Casini, Arianna
    Leone, Stefano
    Vaccaro, Rosa
    Vivacqua, Giorgio
    Ceci, Ludovica
    Pannarale, Luigi
    Franchitto, Antonio
    Onori, Paolo
    Gaudio, Eugenio
    Mancinelli, Romina
    [J]. LIFE-BASEL, 2022, 12 (12):
  • [7] SOCS2-enhanced ubiquitination of SLC7A11 promotes ferroptosis and radiosensitization in hepatocellular carcinoma
    Chen, Qianping
    Zheng, Wang
    Guan, Jian
    Liu, Hongxia
    Dan, Yao
    Zhu, Lin
    Song, Yimeng
    Zhou, Yuchuan
    Zhao, Xinrui
    Zhang, Yuhong
    Bai, Yang
    Pan, Yan
    Zhang, Jianghong
    Shao, Chunlin
    [J]. CELL DEATH AND DIFFERENTIATION, 2023, 30 (01) : 137 - 151
  • [8] The Emerging Role of Ferroptosis in Liver Diseases
    Chen, Si
    Zhu, Jun-yao
    Zang, Xin
    Zhai, Yong-zhen
    [J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [9] O-GlcNAcylated c-Jun antagonizes ferroptosis via inhibiting GSH synthesis in liver cancer
    Chen, Yan
    Zhu, Guoqing
    Liu, Ya
    Wu, Qi
    Zhang, Xiao
    Bian, Zhixuan
    Zhang, Yue
    Pan, Qiuhui
    Sun, Fenyong
    [J]. CELLULAR SIGNALLING, 2019, 63
  • [10] CRISPR screens uncover protective effect of PSTK as a regulator of chemotherapy-induced ferroptosis in hepatocellular carcinoma
    Chen, Yiran
    Li, Li
    Lan, Jie
    Cui, Yang
    Rao, Xiaosong
    Zhao, Jing
    Xing, Tao
    Ju, Gaoda
    Song, Guangtao
    Lou, Jizhong
    Liang, Jun
    [J]. MOLECULAR CANCER, 2022, 21 (01)